Collaboration revenue

Ziopharm
Synthetic Biologics
Oragenics
Fibrocell Science
Genopaver
S&I Opthalmic
OvaXon
Intrexon Energy Partners, LLC
Ares Trading S.A.
Persea Bio, LLC
Thrive Agrobiotics
Intrexon Energy Partners II, LLC
Other
Total
Total revenue
% collaboration revenue

CY12

CY13

CY14

CY15

11,401
620
836
219

10,395
3,235
2,190
4,706
1,139
417

14,621
925
1,643
6,192
1,783
2,832
2,799
6,102

630
13,706

1,443
23,525

8,316
45,213

19,306
6,535
12,179
3,829
4,115
2,540
13,447
4,728
1,241
266
167
19,468
87,821

13,774
99.5%

23,760
99.0%

71,930
62.9%

173,605
50.6%

Related party receivables

% y/y grow th
% of collaborative revenues

CY12
531
4%

CY13
5,285
895%
22%

CY14
12,622
139%
28%

CY15
23,597
87%
27%

o
o

o
o

o
o

o
o

o
o

o
o
o

o
o
o
o
o
o

o
o
o
o
o

Trans Ova purchase price

FTM revenue
Price/revenue
XON EV/ CY16 revenue

If M&A done on 1/1/13

Actual (ex-M&A)

Contribution from M&A

% y/y growth

127,875
72,812
1.8x
20.0x

CY13

86,991
23,760
63,231

CY14

119,721
45,578

74,143
17%

Total revenue
o/w Trans Ova
o/w collaboration revenues

Revenue ex-Trans Ova/collaboration

% of revenue

CY13

CY14

23,760
23,525

71,930
26,352
45,212

235
1.0%

366
0.5%

CY15
173,605
84,743
87,821

1,041
0.6%